Navigation Links
Ameritox and Ingenuity Health Building Comprehensive Reference Database to Help Assess Medication Adherence in those with Serious Mental Illness
Date:8/14/2014

BALTIMORE, Aug. 14, 2014 /PRNewswire/ -- AmeritoxSM, the nation's leader in medication monitoring solutions, today launched a method to help assess medication adherence in behavioral health patients prescribed the antipsychotic drug Seroquel XR, one of the 40 best-selling medications in the U.S. This new method marks a critical step toward building a comprehensive reference database, providing behavioral health clinicians help in addressing the acute problem of medication non-adherence in those with serious mental illness.

Ameritox's Ingenuity Health service conducted research that allows it to provide additional information about whether a patient may be taking Seroquel XR correctly. By comparing normalized urine drug results against the results of patients clinically assessed as adherent, behavioral health centers and medical professionals will have more information as they manage and treat patients prescribed Seroquel XR.

"The singular problem of a lack of insight into whether a person is taking the medication prescribed has long been a barrier to helping those with serious mental illness," said Mike DeGeorge, Director of Medical Affairs for Ameritox and Ingenuity Health. "This method helps address the problem that behavioral health clinicians face with 50 percent of their patients: medication non-adherence."

Seroquel XR, a branded form of quetiapine, is the second antipsychotic medication for which Ingenuity Health has established a reference range for better assessing medication adherence. In March, Ingenuity Health introduced a reference range for Abilify, the nation's top-selling medication.

In developing these reference ranges, Ingenuity Health is building a database for comparing a patient's urine drug test results with those of a group of patients clinically assessed as adherent and taking the same medication. This database will expand Ameritox's exclusive Rx Guardian CDSM, which goes beyond traditional data gathering to provide analysis that can help clinicians address the growing problem of pain medication misuse, abuse and diversion.

Additional research is underway to develop similar reference ranges for other commonly prescribed antipsychotics.

About Ameritox

Ameritox helped pioneer the prescription drug monitoring necessary to address the national epidemic of prescription drug misuse, abuse, and diversion. As the nation's trusted leader in Pain Medication Monitoring SolutionsSM, Ameritox provides medical and business professionals with data-driven analysis and tailored solutions that can improve patient care and prevent tragedy. Ameritox, headquartered in Baltimore, Md., has 800 employees nationwide and laboratory facilities in Greensboro, N.C.

Visit the Ameritox website at: www.ameritox.com

Follow Ameritox on Twitter: www.twitter.com/ameritox

Watch Ameritox on YouTube: www.youtube.com/ameritox

www.ingenuityhealth.com


'/>"/>
SOURCE Ameritox
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers
2. Ameritox Leadership Supports Lawmakers, Pain Practitioners and Patients Confronting Crisis in Pain Medication Abuse
3. Ameritox and Wake Forest University Form Research Partnership
4. Ameritox Appoints New CEO, Scott Walton
5. Bath Salts: With Dangerous Drug Use on the Rise, Ameritox Launches Critical New Test to Help Detect Designer Drug
6. Millennium Laboratories Wins Lawsuit: Ameritox Advertisements Regarding Rx Guardian and Rx Guardian CD Contain Literally False Statements
7. Ameritox Announces Educational Resources to Help Physicians Navigate Complex Compliance Issues
8. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
9. QIAGEN Offers Clinical Labs Early Access to New Ingenuity Solution for Streamlined Interpretation of Patient Sequencing Data
10. QIAGEN Significantly Expands its Offering of Assay Panels for Next-generation Sequencing (NGS) Complemented by Ingenuity Analysis and Interpretation Capabilities
11. Ingenuity Systems Announces Awardees of Grant Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... Germany and GERMANTOWN, Maryland , ... QGEN ; Frankfurt Prime Standard: QIA) today announced ... agreement with Therawis Diagnostics GmbH to develop and commercialize predictive ... and market PITX2 as a marker to predict effectiveness of ... patients. "We are pleased to partner with Therawis, ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... CAMBRIDGE, England , May 25, 2016 /PRNewswire/ ... genomics company employing the precision of circulating tumour ... oncology, today announces the appointment of Professor ... will provide medical leadership across the clinical development ... that Inivata,s products help deliver significant improvements in ...
Breaking Medicine Technology:
(Date:5/28/2016)... California (PRWEB) , ... May 28, 2016 , ... "Color ... to drag and drop a preset onto their media," said Christina Austin - CEO ... Film Studios, editors can quickly and easily add stylish color grades to their footage. ...
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... May 27, 2016 , ... An influential resource amongst nurses and ... to shed lights on the variety of topics detailing why we appreciate nurses in ... why this career has gone from being in a major recession to one of ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... help educate the many who are unaware of the plight of aphasia. In ... run within the “Stroke Awareness” campaign. , The link between stroke and aphasia ...
(Date:5/27/2016)... PALMYRA, Wis. (PRWEB) , ... May 27, 2016 ... ... over $90,000 in scholarships to students studying complementary medicine. Allison Outerbridge is this ... She accepted her award on May 18 at the university’s Student Leadership Awards ...
Breaking Medicine News(10 mins):